In non-excitable cells, the inositol 1,4,5-trisphosphate receptor (IP 3 R) is an intracellular Ca 2C channel, which plays a major role in Ca 2C signalling. Three isoforms of IP 3 R have been identified (IP 3 R-1, IP 3 R-2 and IP 3 R-3) and most cell types express different proportions of each isoform. The differences between the pharmacological and functional properties of the various isoforms of IP 3 R are poorly understood. AR4-2J cells, which express almost exclusively (w86%) the IP 3 R-2, represent an interesting model to study this particular isoform. Here, we investigated a regulatory mechanism by which protein kinase C (PKC) influences IP 3 R-2-mediated Ca 2C release. Using an immunoprecipitation approach, we confirmed that AR4-2J cells express almost exclusively the IP 3 R-2 isoform. Using an in vitro phosphorylation assay, we showed that the immunopurified IP 3 R-2 was efficiently phosphorylated by exogenous PKC. In intact AR4-2J cells metabolically labelled with 32 Pi, we showed that phorbol-12-myristate-13-acetate (PMA) and Ca 2C mobilizing agonists cause the phosphorylation of IP 3 R-2. In saponin-permeabilized AR4-2J cells, IP 3 -induced Ca 2C release was reduced after a pre-treatment with PMA or with exogenous PKC. PMA also reduced the Ca 2C response of intact AR4-2J cells stimulated with carbachol and epidermal growth factor, two agonists that use different receptor types to activate phospholipase C. These results demonstrate that PKC decreases the Ca 2C mobilizing activity of IP 3 R-2 and thus exerts a negative feedback on the agonists-induced Ca 2C response of AR4-2J cells.